Selected research
Industry Growth & Trends
Global Pharmaceutical Validation Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharmaceutical Validation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Validation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharmaceutical Validation Services market include Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services) and Navitas pharma READY, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmaceutical Validation Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Validation Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Validation Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Validation Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Validation Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Validation Services Market by Company
Arbor Group
ATS Global
Catalent
CRS Pharma Solutions
Eurofins Scientific
Körber Pharma
Merck Millipore
MTS (Meissner Technical Services)
Navitas pharma READY
PharmOut
SGS
Sigma-Aldrich
SL Controls
Transcat
Pharmaceutical Validation Services Segment by Type
Pharmaceutical Cleaning Validation Services
Pharmaceutical Equipment Validation Services
Others
Pharmaceutical Validation Services Segment by Application
Pharmaceutical Companies
Biotechnological Companies
Academic and Research Institutes
Pharmaceutical Validation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Validation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Validation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Validation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmaceutical Validation Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Cleaning Validation Services
- Pharmaceutical Equipment Validation Services
- Others
Applications
- Pharmaceutical Companies
- Biotechnological Companies
- Academic and Research Institutes
Companies covered
- Arbor Group
- ATS Global
- Catalent
- CRS Pharma Solutions
- Eurofins Scientific
- Körber Pharma
- Merck Millipore
- MTS (Meissner Technical Services)
- Navitas pharma READY
- PharmOut
- SGS
- Sigma-Aldrich
- SL Controls
- Transcat
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmaceutical Validation Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmaceutical Validation Services Market Size by Region (2021-2032)
- 1.4.1 Global Pharmaceutical Validation Services Market Size by Region (2021-2026)
- 1.4.2 Global Pharmaceutical Validation Services Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmaceutical Validation Services Market Size (2021-2032)
- 1.5.1 North America Pharmaceutical Validation Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmaceutical Validation Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmaceutical Validation Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmaceutical Validation Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmaceutical Validation Services Market Size Growth Rate (2021-2032)
2 Pharmaceutical Validation Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Pharmaceutical Cleaning Validation Services
- 2.1.2 Pharmaceutical Equipment Validation Services
- 2.1.3 Others
- 2.2 Global Pharmaceutical Validation Services Market Size by Type
- 2.2.1 Global Pharmaceutical Validation Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmaceutical Validation Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmaceutical Validation Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmaceutical Validation Services Market Size by Regions
- 2.3.1 North America Pharmaceutical Validation Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmaceutical Validation Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmaceutical Validation Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmaceutical Validation Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmaceutical Validation Services Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Validation Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Biotechnological Companies
- 3.1.3 Academic and Research Institutes
- 3.2 Global Pharmaceutical Validation Services Market Size by Application
- 3.2.1 Global Pharmaceutical Validation Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmaceutical Validation Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmaceutical Validation Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmaceutical Validation Services Market Size by Regions
- 3.3.1 North America Pharmaceutical Validation Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmaceutical Validation Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmaceutical Validation Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmaceutical Validation Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmaceutical Validation Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmaceutical Validation Services Industry Trends
- 4.2 Pharmaceutical Validation Services Industry Drivers
- 4.3 Pharmaceutical Validation Services Industry Opportunities and Challenges
- 4.4 Pharmaceutical Validation Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmaceutical Validation Services Revenue (2021-2026)
- 5.2 Global Pharmaceutical Validation Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmaceutical Validation Services Key Company Headquarters & Area Served
- 5.4 Global Pharmaceutical Validation Services Company, Product Type & Application
- 5.5 Global Pharmaceutical Validation Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmaceutical Validation Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmaceutical Validation Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmaceutical Validation Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Arbor Group
- 6.1.1 Arbor Group Company Information
- 6.1.2 Arbor Group Business Overview
- 6.1.3 Arbor Group Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Arbor Group Pharmaceutical Validation Services Product Portfolio
- 6.1.5 Arbor Group Recent Developments
- 6.2 ATS Global
- 6.2.1 ATS Global Company Information
- 6.2.2 ATS Global Business Overview
- 6.2.3 ATS Global Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 ATS Global Pharmaceutical Validation Services Product Portfolio
- 6.2.5 ATS Global Recent Developments
- 6.3 Catalent
- 6.3.1 Catalent Company Information
- 6.3.2 Catalent Business Overview
- 6.3.3 Catalent Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Catalent Pharmaceutical Validation Services Product Portfolio
- 6.3.5 Catalent Recent Developments
- 6.4 CRS Pharma Solutions
- 6.4.1 CRS Pharma Solutions Company Information
- 6.4.2 CRS Pharma Solutions Business Overview
- 6.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CRS Pharma Solutions Pharmaceutical Validation Services Product Portfolio
- 6.4.5 CRS Pharma Solutions Recent Developments
- 6.5 Eurofins Scientific
- 6.5.1 Eurofins Scientific Company Information
- 6.5.2 Eurofins Scientific Business Overview
- 6.5.3 Eurofins Scientific Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eurofins Scientific Pharmaceutical Validation Services Product Portfolio
- 6.5.5 Eurofins Scientific Recent Developments
- 6.6 Körber Pharma
- 6.6.1 Körber Pharma Company Information
- 6.6.2 Körber Pharma Business Overview
- 6.6.3 Körber Pharma Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Körber Pharma Pharmaceutical Validation Services Product Portfolio
- 6.6.5 Körber Pharma Recent Developments
- 6.7 Merck Millipore
- 6.7.1 Merck Millipore Company Information
- 6.7.2 Merck Millipore Business Overview
- 6.7.3 Merck Millipore Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Merck Millipore Pharmaceutical Validation Services Product Portfolio
- 6.7.5 Merck Millipore Recent Developments
- 6.8 MTS (Meissner Technical Services)
- 6.8.1 MTS (Meissner Technical Services) Company Information
- 6.8.2 MTS (Meissner Technical Services) Business Overview
- 6.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 MTS (Meissner Technical Services) Pharmaceutical Validation Services Product Portfolio
- 6.8.5 MTS (Meissner Technical Services) Recent Developments
- 6.9 Navitas pharma READY
- 6.9.1 Navitas pharma READY Company Information
- 6.9.2 Navitas pharma READY Business Overview
- 6.9.3 Navitas pharma READY Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Navitas pharma READY Pharmaceutical Validation Services Product Portfolio
- 6.9.5 Navitas pharma READY Recent Developments
- 6.10 PharmOut
- 6.10.1 PharmOut Company Information
- 6.10.2 PharmOut Business Overview
- 6.10.3 PharmOut Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 PharmOut Pharmaceutical Validation Services Product Portfolio
- 6.10.5 PharmOut Recent Developments
- 6.11 SGS
- 6.11.1 SGS Company Information
- 6.11.2 SGS Business Overview
- 6.11.3 SGS Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 SGS Pharmaceutical Validation Services Product Portfolio
- 6.11.5 SGS Recent Developments
- 6.12 Sigma-Aldrich
- 6.12.1 Sigma-Aldrich Company Information
- 6.12.2 Sigma-Aldrich Business Overview
- 6.12.3 Sigma-Aldrich Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Sigma-Aldrich Pharmaceutical Validation Services Product Portfolio
- 6.12.5 Sigma-Aldrich Recent Developments
- 6.13 SL Controls
- 6.13.1 SL Controls Company Information
- 6.13.2 SL Controls Business Overview
- 6.13.3 SL Controls Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 SL Controls Pharmaceutical Validation Services Product Portfolio
- 6.13.5 SL Controls Recent Developments
- 6.14 Transcat
- 6.14.1 Transcat Company Information
- 6.14.2 Transcat Business Overview
- 6.14.3 Transcat Pharmaceutical Validation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Transcat Pharmaceutical Validation Services Product Portfolio
- 6.14.5 Transcat Recent Developments
7 North America
- 7.1 North America Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 7.3 North America Pharmaceutical Validation Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 8.3 Europe Pharmaceutical Validation Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmaceutical Validation Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 10.3 South America Pharmaceutical Validation Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmaceutical Validation Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst